Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...
EMERYVILLE, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc. (NASDAQ: VANI), an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic ...
Researchers at the Netherlands Institute for Neuroscience have become the first to fully characterize cell activity from a little relay station in the center of the human brain. This aids our ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
In collaboration with their colleagues at the Donders Institute, researchers at the Netherlands Institute for Neuroscience have developed a simulator that enables artificial visual observations for ...
Vivani Medical plans to spin off Cortigent, allowing both companies to focus on their specialized therapeutic areas by Q3 2025. Vivani Medical, Inc. has announced plans to spin off its subsidiary, ...
Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...
Cortical blindness occurs when a person loses their visual perception due to damage to certain areas of the brain. The eyes work as usual, but the brain cannot process visual information. The damage ...
In collaboration with their colleagues at the Donders Institute, researchers at the Netherlands Institute for Neuroscience have developed a simulator that enables artificial visual observations for ...